Cite
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
MLA
Chen, De, et al. “Aberrant S100A16 Expression Might Be an Independent Prognostic Indicator of Unfavorable Survival in Non-Small Cell Lung Adenocarcinoma.” PLoS ONE, vol. 13, no. 5, May 2018, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0197402.
APA
Chen, D., Luo, L., & Liang, C. (2018). Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma. PLoS ONE, 13(5), 1–12. https://doi.org/10.1371/journal.pone.0197402
Chicago
Chen, De, Linjie Luo, and Chao Liang. 2018. “Aberrant S100A16 Expression Might Be an Independent Prognostic Indicator of Unfavorable Survival in Non-Small Cell Lung Adenocarcinoma.” PLoS ONE 13 (5): 1–12. doi:10.1371/journal.pone.0197402.